Aimmune Therapeutics Inc.

(AIMT) Trade

By |

Profile

Aimmune Therapeutics Inc is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The Company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.

Contact Information

Website: www.aimmune.com
Email: dsheel@aimmune.com
Main Phone: +1 650 614-5220
Address: 8000 Marina Boulevard
Address 2: Suite 300
State: CA
City / Town: Brisbane
Country: US
Postal Code: 94005

Issuer Information

Exchange: NGS
CEO: Jayson Donald Alexander Dallas
Employees: 339
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Aimmune Therapeutics Inc is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The Company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.

Contact Information

Website: www.aimmune.com
Email: dsheel@aimmune.com
Main Phone: +1 650 614-5220
Address: 8000 Marina Boulevard
Address 2: Suite 300
State: CA
City / Town: Brisbane
Country: US
Postal Code: 94005

Issuer Information

Exchange: NGS
CEO: Jayson Donald Alexander Dallas
Employees: 339
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 34.31 $ -0.01 (-0.03%)
Last Price 34.31 Change $ -0.01 Change % -0.03 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 34.31 High 34.32 Low 34.28 Prev Close 34.32
Last Trade Volume 1.1 mi 52 Wk Hi 37.00 52 Wk Low 10.10
Market Cap 2.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 65,450,142.00 EPS (TTM) -4.49 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 27 159
Number of Buys 15 67
Number of Sells 12 92
Net Activity 22500 -249363
Last 10 Buys Shares
Kathryn E. Falberg 1,000
Mark Iwicki 1,000
Eric H. Bjerkholt 1,000
Patrick G. Enright 1,000
Eric H. Bjerkholt 1,000
Patrick G. Enright 1,000
Patrick G. Enright 1,000
Patrick G. Enright 1,000
Patrick G. Enright 1,000
Patrick G. Enright 1,000
Last 10 Sell Shares
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 80 80 80 80
Low Target Price Estimate 53 53 53 53
Mean Target Price Estimate 64 64 64 64
Standard Deviation 9.47 9.47 9.47 9.47
Date of Most Recent Estimate 05/31/18 05/22/18 05/22/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 7
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.13 1.13 1.13 1.13